GlassScriptPhysician profile
Jawwad J Khan
NPI 1457553570
$7,613.18
in general payments reported to CMS, 2019-2025
13 companies · $288 in 2025
The $288 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $66.17 · 2020: $32.20 · 2021: $103 · 2022: $6,489 · 2023: $365 · 2024: $269 · 2025: $288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.24 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,540.77 | 2022-2025 | |
| Abbvie INC. | $330.99 | 2021-2025 | |
| Astellas Pharma US INC | $319.99 | 2023-2024 | Veozah |
| Sumitomo Pharma America, INC. | $126.58 | 2023 | Myfembree |
| Organon LLC | $67.91 | 2021-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $64.99 | 2019-2024 | Aptima |
| Merck Sharp & Dohme LLC | $40.98 | 2019-2020 | |
| Medtronic, INC. | $31.58 | 2024 | Ligasure |
| Optumhealth Care Solutions, LLC | $27.75 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coloplast Corp | $19.23 | 2020 | |
| Coopersurgical, INC. | $18.42 | 2025 | Paragard T 380a |
| Pfizer INC. | $14.23 | 2019 | |
| Meditrina | $9.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jawwad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.